| Earnings per Share Attributable to Common Stockholders |
Earnings per Share Attributable to Common Stockholders The following table sets forth the computation of basic and diluted earnings per share attributable to common stockholders for the periods presented (in thousands, except per share and share amounts): | | | | | | | | | | | | | | | | | | | Fiscal Year Ended January 31 | | 2026 | | 2025 | | 2024 | | Basic earnings per share | | | | | | | Numerator: | | | | | | Net income (loss) attributable to common stockholders | $ | (42,066) | | | $ | 194,447 | | | $ | 76,966 | | | Denominator: | | | | | | | Weighted-average number of common stock outstanding used in computing earnings per share, basic | 56,647,662 | | 38,990,556 | | 37,297,221 | | Earnings per share attributable to common stockholders, basic | $ | (0.74) | | | $ | 4.99 | | | $ | 2.06 | | | | | | | | | Diluted earnings per share | | | | | | | Numerator: | | | | | | Net income (loss) attributable to common stockholders, basic | $ | (42,066) | | | $ | 194,447 | | | $ | 76,966 | | | Fair value adjustment for the convertible note, net of tax effect | — | | | (12,695) | | | 953 | | | Fair value adjustment for liability-classified Series G Warrant, net of tax effect | (893) | | | — | | | — | | | Fair value adjustment for liability-classified common stock warrant, net of tax effect | (244) | | | — | | | — | | Net income (loss) attributable to common stockholders, dilutive | $ | (43,203) | | | $ | 181,752 | | | $ | 77,919 | | | Denominator: | | | | | | | Weighted-average number of common stock outstanding used in computing earnings per share, basic | 56,647,662 | | 38,990,556 | | 37,297,221 | | Conversion of the convertible note | — | | | 492,096 | | | 6,888,298 | | | Conversion of redeemable convertible preferred stock, all series | — | | | 69,914,359 | | | 69,914,359 | | | Dilutive effect of stock options | — | | | 27,962,907 | | | 28,567,993 | | | Dilutive effect of equity-classified common stock warrants | — | | | 1,300,400 | | | 1,210,425 | | Dilutive effect of liability-classified Series G Warrant | 164,242 | | — | | | — | | Dilutive effect of liability-classified common stock warrant | 78,552 | | — | | | — | | | Weighted-average number of common stock outstanding used in computing earnings per share, dilutive | 56,890,456 | | | 138,660,318 | | | 143,878,296 | | Earnings (loss) per share attributable to common stockholders, diluted | $ | (0.76) | | | $ | 1.31 | | | $ | 0.54 | |
The following common stock equivalents were excluded from the computation of diluted earnings per share attributable to common stockholders because including them would have been antidilutive (outstanding): | | | | | | | | | | | | | Fiscal Year Ended January 31 | | 2026 | | 2025 | | Liability-classified common stock warrant | — | | | 60,000 | | | Series G Warrant | — | | | 251,750 | | | Dual-trigger RSUs | 15,676,155 | | | 31,308,443 | | | SAFEs | Various | | Various | | | | | | | | | | Options | 23,755,365 | | | — | | | Equity-classified common stock warrants | 1,641,713 | | | — | |
Upon the completion of the IPO, the Series G Warrant was automatically converted to being exercisable for common stock. Accordingly, it is included as a liability-classified common stock warrant for the fiscal year ended January 31, 2026.
|